4//SEC Filing
Lock Kenneth A. 4
Accession 0001567619-22-006226
CIK 0001787306other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:15 PM ET
Size
6.0 KB
Accession
0001567619-22-006226
Insider Transaction Report
Form 4
Lock Kenneth A.
Chief Commercial Officer
Transactions
- Sale
Common Stock
2022-03-01$17.75/sh−935$16,599→ 31,734 total
Footnotes (4)
- [F1]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs"). Shares and RSUs remain subject to a lock-up agreement with the underwriters for the Issuer's follow-on offering in February 2021.
- [F2]The transaction was executed in multiple trades in prices ranging from $17.40 to $18.185, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Includes 1,002 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan as follows: 964 shares on May 31, 2021 and 38 shares on November 30, 2021.
- [F4]Includes 14,000 RSUs.
Documents
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
Related Parties
1- filerCIK 0001801047
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:15 PM ET
- Size
- 6.0 KB